RecruitingNCT00801372

Use of Existing Fibroblast Cells to Convert to Induced Pluripotent Stem Cells


Sponsor

Hadassah Medical Organization

Enrollment

1 participants

Start Date

Nov 1, 2008

Study Type

OBSERVATIONAL

Conditions

Summary

Induced pluripotent stem cells potentially may be useful in the future as an unlimited source of cells for transplantation. The major goal of the project is to develop human iPS cells from existing lines of fibroblasts that were originally donated as clinical grade feeders for the development of clinical grade hESCs. The clinical grade feeders were developed from aborted fetuses, foreskin and umbilical cord.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with healthy male newborns and pregnant, healthy females. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Hadassah Ein Kerem

Jerusalem, Israel, Israel

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00801372